Sobre
Dr Fahad Ibnshamsah is a highly respected Consultant Medical Oncologist and Internal Medicine Specialist. He is dedicated to providing comprehensive and compassionate care to patients facing complex oncological diagnoses. With a strong commitment to advancing cancer treatment, he combines evidence-based medicine with a reassuring approach, ensuring that each patient receives a personalised treatment plan tailored to their specific needs. He also serves as an Assistant Professor of Internal Medicine, sharing his extensive clinical expertise with the next generation of medical professionals.
Throughout his career, Dr Ibnshamsah has developed a profound expertise in the diagnosis and management of a wide array of malignancies. His clinical focus encompasses gastrointestinal cancers, including colon and liver cancer, as well as breast, lung, prostate, kidney, and bladder cancers. He is highly skilled in administering advanced therapeutic modalities, ranging from chemotherapy and immunotherapy to targeted therapy and hormone therapy. His multidisciplinary approach ensures that patients benefit from the most innovative and effective treatments available in modern oncology.
Dr Ibnshamsah completed his foundational medical education at King Faisal University before pursuing advanced training internationally. He completed a fellowship in Medical Oncology in 2013, followed by a specialised fellowship in Breast and Gastrointestinal Oncology in 2014, both at the University of Calgary in Canada. Furthermore, he holds a Master of Science in Health Administration from the University of Alabama at Birmingham in the United States. He is an active leader in the medical community and currently serves as the Chief Executive Officer of the Saudi Society of Gastrointestinal Oncology, reflecting his dedication to improving oncological care standards.
Throughout his career, Dr Ibnshamsah has developed a profound expertise in the diagnosis and management of a wide array of malignancies. His clinical focus encompasses gastrointestinal cancers, including colon and liver cancer, as well as breast, lung, prostate, kidney, and bladder cancers. He is highly skilled in administering advanced therapeutic modalities, ranging from chemotherapy and immunotherapy to targeted therapy and hormone therapy. His multidisciplinary approach ensures that patients benefit from the most innovative and effective treatments available in modern oncology.
Dr Ibnshamsah completed his foundational medical education at King Faisal University before pursuing advanced training internationally. He completed a fellowship in Medical Oncology in 2013, followed by a specialised fellowship in Breast and Gastrointestinal Oncology in 2014, both at the University of Calgary in Canada. Furthermore, he holds a Master of Science in Health Administration from the University of Alabama at Birmingham in the United States. He is an active leader in the medical community and currently serves as the Chief Executive Officer of the Saudi Society of Gastrointestinal Oncology, reflecting his dedication to improving oncological care standards.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Fahad Ibnshamsah
Educação e formação
-
2011–2017 MD · Medicine and Surgery
-
2017–2021 Residency · Oncologia
Carreira e nomeações
-
2021-09–2022-08 Junior consultant
Licenças e seguros
Licenças médicas
SA — Organización Médica Colegial de España (OMC)
Certificações do conselho
European Board of Oncologia
Seguro de responsabilidade profissional:
HDI Global · 3,000,000 EUR cobertura · No claims on file
Procedimentos realizados
| Procedimento | Código | Total acumulado |
|---|---|---|
| GP consultation | 99213 | 956 |
| Annual physical exam | 99395 | 266 |
| Vaccination administration | 90471 | 2,826 |
| Minor procedure (skin) | 17110 | 693 |
Serviços e preços
| Serviço | Duração | Modalidade | Preço |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 120 min | in_clinic | 450.00 EUR |
| Minor procedure (skin) | 30 min | in_clinic | 180.00 EUR |
Consultório, equipa e na prática
Vídeos
Investigação e publicações
índice h: 5 · i10: 7
-
Long-term follow-up of Oncologia across SA
DOI: 10.8710/euroclin.2026.0 · PMID: 37979660 · citado por 180
-
Validation of clinical scoring in Oncologia
DOI: 10.5738/euroclin.2025.1 · PMID: 31282003 · citado por 102
-
Long-term follow-up of Oncologia across SA
DOI: 10.9519/euroclin.2024.2 · PMID: 33838956 · citado por 16
-
Validation of clinical scoring in Oncologia
DOI: 10.4283/euroclin.2023.3 · PMID: 39972240 · citado por 162
Palestras convidadas
- Practical updates in Oncologia European Annual Congress (Oncologia) · Vienna · 2024 · invited
- Single-centre experience in Oncologia National Society Meeting · Dammam · 2023 · oral abstract
Prémios e afiliações
Prémios
- 🏆 Top-rated Oncologia — Dammam · EuroClinics Patient Choice · 2025 · regional
Filiações em sociedades
- WONCA Europe — Family Doctors — Member · Desde 2022
- national college of family doctors — Member · Desde 2022
- European Union of Medical Specialists (UEMS) — Member · Desde 2022
Artigos deste médico
- Patient education Patient guide to Oncologia
- Awareness When should you see a oncologia?
Para pacientes internacionais
- Coordenador
- Patient liaison · fahad.ibnshamsah@euroclinics.example
Localização
1 etiquetaAvaliações dos pacientes
Partilhe a sua experiência — ajude outros pacientes a encontrar o médico certo. Escrever uma avaliação →
Avaliações recentes
-
★★★★★ ✓ Verificado Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verificado Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verificado Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.